RDHL — Redhill Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Redhill Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	6-K	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	29.8	38	20	5.57	4.62
Net Total Accounts Receivable
Net Total Receivables	28.7	31.7	34.5	2.59	2.54
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	70.5	89.2	85.9	16.1	11.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.7	4.22	7.19	1.18	0.437
Net Intangible Assets
Other Long Term Assets
Total Assets	180	181	159	23	18
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	73.2	81.5	197	20	22.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	166	172	207	21	22.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	13.9	8.88	-48.4	2.07	-4.68
Total Liabilities & Shareholders' Equity	180	181	159	23	18
Total Common Shares Outstanding